Spring / Summer 2021

Dear KPMP Participant,

At KPMP, we describe participants like you as “our KPMP heroes.” Your participation continuous to be crucial to the success of this research. It’s been six months since we last updated you on KPMP’s progress. Here are some of the ways that our heroes are making an impact.

We reached a significant milestone. So far, 100 people have agreed to participate in KPMP. We completed over 90 biopsies. We recently began enrolling kidney donors and patients with kidney stones into our Indianapolis and Cincinnati enrollment sites. Tissue from these biopsies is being studied all over the country.

We are already learning from the biopsies that we have studied.

KPMP recently published an article about the purpose and importance of the study in the March 1st edition of Kidney International. The article, entitled Rationale and design of the Kidney Precision Medicine Project, describes the aims of our study, and how we hope people with kidney disease will benefit from this project. Members of the KPMP Community Engagement Committee, including kidney patients, wrote an article for CJASN about the importance of community engagement in KPMP: Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project.

Please share these papers with your family and friends. If they want to learn more about KPMP, give them this link to the KPMP Introduction video. 

Though the US continues to be impacted by COVID-19, all recruitment sites are safely enrolling study participants, performing biopsies and conducting follow up visits. KPMP has added an additional study to research how COVID-19infections may affect kidney function in the general population, as well as, in people living with kidney disease.

Your contribution to KPMP has had a significant impact. The KPMP could not exist without volunteers, like you, who have undergone a kidney biopsy. Thank you. Please contact us if you have any questions or comments.

Sincerely,

Clinical Data and sample Coordinating Center (CDCC)
Data Visualization Hub (DVH)
Enhanced clinical phenotyping (OP)
Healthy Reference Tissue (OP)
Indiana University - The Ohio State University (IU-OSU)
Joslin Diabetes Center/Beth Israel Deaconess Medical Center
KPMP Biomarker Measurements (OP)
New Tissue Interrogation Technologies (OP)
PREMIERE (UM-Broad-Princeton)
University of California San Francisco - Stanford University (UCSF-SU)
University of Illinois, Chicago
University of North Carolina
University of Texas Health Science Center at San Antonio - Pacific Northwest National Laboratory - European Molecular Biology Laboratory (UTHSA-PNNL-EMBL)
University of Texas Southwestern, Dallas
Washington University St. Louis
Whole Genome Sequencing (CLIA) (OP)
Natasha Wen
Natasha Wen
Natasha Wen
Research Coordinator
Nicole Marquez
Nicole Marquez
Nicole Marquez
Research Coordinator
Seanee Lefferts
Seanee Lefferts
Seanee Lefferts
Research Coordinator
Shihong Ma
Shihong Ma
Shihong Ma
Research Coordinator
Sonya Shah
Sonya Shah
Sonya Shah
Research Coordinator
Sophia Angus
Sophia Angus
Sophia Angus
Research Coordinator
Sora Lee
Sora Lee
Sora Lee
Research Coordinator
Stephanie Wofford, MS
Stephanie Wofford, MS
Stephanie Wofford, MS
Research Coordinator
Tina Vita
Tina Vita
Tina Vita
Research Coordinator
Ugochukwu Ugwouwu
Ugochukwu Ugwouwu
Ugochukwu Ugwouwu
Research Coordinator
Via Rao
Via Rao
Via Rao
Research Coordinator
Theodore Alexandov
Theodore Alexandov
Theodore Alexandov
Principal Investigator

Please Upgrade Your Browser.

Unfortunately, Internet Explorer is an outdated browser and we do not currently support it. To have the best browsing experience, please upgrade to Microsoft Edge or Google Chrome.

Upgrade